Sorilux Aerosol, Foam
Product Images NDC 51862-376

9 FDA label images from Mayne Pharma · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sorilux (NDC 51862-376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sorilux 01)

Chemical Structure (Sorilux 01)
Chemical structure diagram of calcipotriene, the active ingredient in SORILUX aerosol foam 50 mcg/g topical medication by Mayne Pharma.*
FDA Label Image

Figure A (Sorilux 02)

Figure A (Sorilux 02)
An instructional illustration showing a person dispensing foam from a white aerosol canister. One hand holds the canister upright while the other hand presses the nozzle, demonstrating application technique for topical aerosol foam products like Sorilux (calcipotriene).*
FDA Label Image

Figure B (Sorilux 03)

Figure B (Sorilux 03)
An instructional or anatomical image showing a hand holding and using a white aerosol foam canister. The image demonstrates the proper grip or dispensing technique for the topical aerosol foam device, likely related to the application of the product.*
FDA Label Image

Figure C (Sorilux 04)

Figure C (Sorilux 04)
An instructional image showing a person dispensing a foam from a topical aerosol canister onto the palm of their hand, demonstrating proper application technique for a foam medication.*
FDA Label Image

Figure D (Sorilux 05)

Figure D (Sorilux 05)
A black and white image showing a hand dispensing foam onto the palm from a foam dispenser can. The foam is visibly coming out of the nozzle, and the receiving hand is open to catch the foam, demonstrating application or usage of a topical foam product.*
FDA Label Image

Figure E (Sorilux 06)

Figure E (Sorilux 06)
A black-and-white illustration showing a person's hands applying foam medication to the inner side of their elbow. The foam is dispensed onto one hand, while the other hand is positioned to spread it, demonstrating topical application technique.*
FDA Label Image

Figure F (Sorilux 07)

Figure F (Sorilux 07)
An instructional black and white photo showing a person applying a topical medication to their knee, demonstrating the proper use of a topical aerosol foam product on skin.*
FDA Label Image

Figure G (Sorilux 08)

Figure G (Sorilux 08)
An image illustrating the application of topical medication to the scalp. A person's hand is shown applying foam or cream to a section of scalp with visible hair parted, demonstrating how to apply the product directly to the affected area.*
FDA Label Image

Principal Display Panel (60 gram Can Carton)

Principal Display Panel (60 gram Can Carton)
Carton labeling for Sorilux foam 0.005% (calcipotriene) topical aerosol by Mayne Pharma, containing 60 grams. The packaging includes usage instructions, warnings about flammability and proper storage, a barcode, and manufacture details stating the product is made in Israel. The label highlights Rx only status and directs patients to contact Mayne Pharma or the FDA for adverse reactions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.